Acta oncologica (Stockholm, Sweden), vol.38, no.8, pp.1011-5, 1999 (SCI-Expanded)
This study was conducted to investigate the distribution of metastatic lesions and their influence on survival, as well as other prognostic Factors previously shown to have an impact on the outcome of patients with extensive small cell lung cancer (SCLC). Of the 207 patients were included and retrospectively analyzed; 124 patients had extended disease at initial presentation and the remaining 83 developed metastatic disease during follow-up. Patients who relapsed presented most frequently with distant metastases. The brain was the most frequent organ targeted for metastatic disease following the completion of chemotherapy (p < 0.05). Serum LDH levels correlated significantly with the presence of liver metastasis (p < 0.001). The site of involvement did not seem to have an impact on survival. Nevertheless, patients with multiple metastatic sites had a significantly poor survival rate (p = 0.001). Weight loss, performance status, gender, clinical stage, serum LDH and albumin levels were all shown to correlate with survival (p < 0.05). Response to chemotherapy was determined to be the most important prognostic factor.